MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.
2 reports, 2 independent
Updated Sep 24
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided analyst ratings and targets for small-cap healthcare companies Emergent BioSolutions and Entrada Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Emergent BioSolutions
multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
Nothing else this week.
-
MarketBeat
American personal finance blog
Related events
- MarketBeat reported analyst recommendations for small-cap technology companies Energous Corporation and Magnachip Semiconductor.
- MarketBeat reported analyst recommendations for Cytokinetics and Gain Therapeutics, two competing healthcare companies.
- MarketBeat reported analyst recommendations, noting that both MarketBeat and Jefferies Financial Group are mid-cap finance companies.
- MarketBeat provided analyst ratings for small-cap healthcare companies Arvinas, Inc. and uniQure N.V.
- MarketBeat reported analyst recommendations for small-cap finance companies Perella Weinberg Partners and Fidus Investment.